AIM ImmunoTech CEO Thomas K. Equels Participates in Fireside Chat with Ascendiant Capital Markets Analyst Ed Woo

NEXT STORY
Made of Millions Shines Light on Shame and its Effect on Mental Health and Wellness in New “Shame Shouldn’t Be a Symptom” Collage Art Campaign Featuring Up and Coming Artist Ian Woods
PREV STORY
Respiratory Devices And Equipment (Therapeutic And Diagnostic) Global Market Report 2021: COVID 19 Implications And Growth to 2030
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

BioXcel Therapeutics Announces Completion of Pre-NDA Meeting with FDA for BXCL501 for the Acute Treatment of Agitation in Patients with Schizophrenia and Bipolar Disorders

author_avatar
NASDAQ Market News

BeyondSpring Announces Submission of New Drug Application to U.S. FDA and China NMPA for Plinabulin and G-CSF Combination for the Prevention of Chemotherapy-Induced Neutropenia (CIN)

author_avatar
NASDAQ Market News

SELLAS Life Sciences Presents Interim Phase 1 Clinical Data of Galinpepimut-S (GPS) in Combination with Nivolumab to Treat Wilms Tumor 1 Positive (WT1+) Ovarian Cancer Patients at ASCO 2018

1-year progression-free survival (PFS) rate of 70% with induction of serum levels of WT1 ...

author_avatar
NASDAQ Market News